Special Programs In Ethnic & Cultural Diversity At San Francisco General Receive National Award

April 14, 1999

A group of patient programs at San Francisco General Hospital Medical Center that focus on ethnic and cultural diversity has received a top honor from the American College of Psychiatrists.

The 1999 Award for Creativity in Psychiatric Education was awarded to the SFGHMC Ethnic/Minority Psychiatric Inpatient Programs, which provide special services to patients who are Asian, Latino, black, gay/lesbian, have AIDS or related diseases, or are women.

The programs are recognized nationwide as the only ones of their kind to focus on the impact of culture and ethnicity on the way mentally ill patients experience and deal with their distress.

Francis G. Lu, M.D., UC San Francisco clinical professor of psychiatry and director of the Cultural Competence and Diversity Program in the SFGHMC Department of Psychiatry, initiated the first program in the group in 1980--the Asian Focus Program--and has been instrumental in development of the others. Robert L. Okin, M.D., chief of psychiatry at SFGHMC, oversees direction of the programs.

In addition to their patient service component, the programs provide educational training in cultural psychiatry to health care professionals.

"While focusing on different populations, the programs share a commitment to providing care that is sensitive to the cultural background and particular needs of their patients, to training others to deliver such care, and to advancing research into the psychiatric treatment of these ethnic/minority groups," Lu said.
SFGHMC is affiliated with UCSF and is part of the Community Health Network of San Francisco, the City's integrated health care delivery system that also includes Laguna Honda Hospital and Rehabilitation Center, 18 community health centers, and home health and jail health services.

University of California - San Francisco

Related Psychiatry Articles from Brightsurf:

The Lancet Psychiatry: First UK-wide study describes brain complications in some patients with severe COVID-19
A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease and is published today in The Lancet Psychiatry journal.

Revisiting the potential of using psychedelic drugs in psychiatry
Before they were banned about a half century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders.

Psychiatry: Five clearly defined patterns
Psychiatrists led by Nikolaos Koutsouleris from Ludwig-Maximilians-Universitaet (LMU) in Munich have used a computer-based approach to assign psychotic patients diagnosed as bipolar or schizophrenic to five different subgroups.

The Lancet Psychiatry: Life-course-persistent antisocial behaviour may be associated with differences in brain structure
Individuals who exhibit life-course-persistent antisocial behaviour - for example, stealing, aggression and violence, bullying, lying, or repeated failure to take care of work or school responsibilities - may have thinner cortex and smaller surface area in regions of the brain previously implicated in studies of antisocial behaviour more broadly, compared to individuals without antisocial behaviour, according to an observational study of 672 participants published in The Lancet Psychiatry journal.

The Lancet Psychiatry: Abortion does not increase a woman's risk of attempting suicide
Policies based on the notion that undergoing an abortion causes or increases women's risk of suicide attempts are misinformed, according to the results of a 17-year-long observational study including more than half a million 18 to 36-year-old Danish women who had a first, first-trimester abortion, published in The Lancet Psychiatry journal.

How artificial intelligence can transform psychiatry
Scientists have developed a new mobile app that categorizes mental health status based on speech patterns.

The Lancet Psychiatry: Improved support after self-harm needed to reduce suicide risk
To reduce the high risk of suicide after hospital attendance for self-harm, improved clinical management is needed for all patients - including comprehensive assessment of the patients' mental state, needs, and risks, as well as implementation of risk reduction strategies, including safety planning.

The Lancet Psychiatry: Insufficient evidence that medicinal cannabinoids improve mental health
The most comprehensive analysis of medicinal cannabinoids and their impact on six mental health disorders -- combining 83 studies including 3,000 people -- suggests that the use of cannabinoids for mental health conditions cannot be justified based on the current evidence.

'Spin' found in over half of clinical trial abstracts published in top psychiatry journals
'Spin' -- exaggerating the clinical significance of a particular treatment without the statistics to back it up -- is apparent in more than half of clinical trial abstracts published in top psychology and psychiatry journals, finds a review of relevant research in BMJ Evidence Based Medicine.

The Lancet Psychiatry: Compensatory strategies to disguise autism spectrum disorder may delay diagnosis
For the first time, compensatory strategies used by people with autism have been investigated and collated in a qualitative study using an online survey of 136 adults, published in The Lancet Psychiatry journal.

Read More: Psychiatry News and Psychiatry Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.